David James Wilson
Corporate Officer/Principal bei HAEMONETICS CORPORATION
Profil
David James Wilson is currently the Chief Executive Officer & Director at InnovHeart Srl and the President-Plasma Business Unit at Haemonetics Corp.
He previously worked as the President at Cordis Corp.
from 2015 to 2017 and as the President at Mentor Worldwide LLC.
He also served as the Director at California Healthcare Institute.
Mr. Wilson holds an MBA degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Auburn University, and a graduate degree from The University of Alabama at Birmingham.
Aktive Positionen von David James Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 18.09.2017 |
InnovHeart Srl
 InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von David James Wilson
| Unternehmen | Position | Ende |
|---|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | President | 01.08.2017 |
Mentor Worldwide LLC
 Mentor Worldwide LLC Medical SpecialtiesHealth Technology Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA. | President | 01.01.2015 |
| California Healthcare Institute | Director/Board Member | - |
Ausbildung von David James Wilson
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Auburn University | Undergraduate Degree |
| The University of Alabama at Birmingham | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HAEMONETICS CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cordis Corp.
Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Mentor Worldwide LLC
Mentor Worldwide LLC Medical SpecialtiesHealth Technology Mentor Worldwide LLC develops, manufactures and markets science-based products. It offers surgical and non-surgical medical procedures such as breast implants, skin and tissue expanders and facial and dermal implants. The company was founded by Christopher J. Conway in 1969 and is headquartered in Irvine, CA. | Health Technology |
| California Healthcare Institute | Health Technology |
InnovHeart Srl
InnovHeart Srl Medical SpecialtiesHealth Technology InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy. | Health Technology |
